U2Bio Co., Ltd. (KOSDAQ:221800)

U2Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2014	FY 2013
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2014	Dec 31, 2013
Market Capitalization	35,272	30,080	59,596	49,318	-	-
Market Cap Growth	-22.01%	-49.53%	20.84%	-	-	-
Enterprise Value	1,407	-3,866	23,197	52,691	-	-
Last Close Price	3125.00	2665.00	5280.00	6451.26	-	-
PE Ratio	-	-	92.27	3.75	-	-
PS Ratio	1.41	1.20	1.94	0.72	-	-
PB Ratio	1.03	0.87	1.57	1.46	-	-
P/TBV Ratio	1.07	0.88	1.58	1.47	-	-
P/FCF Ratio	-	-	-	2.10	-	-
P/OCF Ratio	-	-	-	2.02	-	-
EV/Sales Ratio	0.06	-	0.75	0.76	-	-
EV/EBITDA Ratio	-	-	-	3.18	-	-
EV/EBIT Ratio	-	-	-	3.35	-	-
EV/FCF Ratio	-2.07	-	-	2.25	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	1.13	2.31
Debt / EBITDA Ratio	-	-	-	0.03	4.77	5.73
Debt / FCF Ratio	-	-	-	0.02	-	-
Asset Turnover	0.55	0.53	0.61	-	1.06	-
Inventory Turnover	25.52	26.49	30.54	-	18.23	-
Quick Ratio	6.68	6.27	5.52	3.22	1.79	1.51
Current Ratio	6.87	6.40	5.64	3.27	1.88	1.64
Return on Equity (ROE)	-7.70%	-7.85%	1.80%	-	9.93%	-
Return on Assets (ROA)	-3.81%	-3.89%	-1.67%	-	4.15%	-
Return on Capital (ROIC)	-4.84%	-4.99%	-2.30%	-	6.34%	-
Return on Capital Employed (ROCE)	-	-	-	43.20%	11.10%	11.90%
Earnings Yield	-7.79%	-9.44%	1.08%	26.68%	-	-
FCF Yield	-1.93%	-5.90%	-4.65%	47.53%	-	-
Payout Ratio	-	-	195.50%	5.76%	-	-
Buyback Yield / Dilution	-6.54%	-10.09%	-1.51%	-598.90%	-22.57%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.